H.C. Wainwright Reiterates Buy Rating on AMAG Pharmaceuticals (AMAG) Following Committee Vote
Tweet Send to a Friend
H.C. Wainwright analyst Douglas Tsao reiterated a Buy rating and $16.00 price target on AMAG Pharmaceuticals (NASDAQ: AMAG) following the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
